Nicotinamide mononucleotide supplementation rescues mitochondrial and energy metabolism functions and ameliorates inflammatory states in the ovaries of aging mice

Abstract

Noninvasive pharmacological strategies like nicotinamide mononucleotide (NMN) supplementation can effectively address age-related ovarian infertility by maintaining or enhancing oocyte quality and quantity. This study revealed that ovarian nicotinamide adenine dinucleotide levels decline with age, but NMN administration significantly restores these levels, preventing ovarian atrophy and enhancing the quality and quantity of ovulated oocytes. Improvements in serum hormone secretion and antioxidant factors, along with decreased expression of proinflammatory factors, were observed. Additionally, a significant increase in the number of ovarian follicles in aging individuals was noted. Scanning electron microscopy data indicated that NMN significantly alters the density and morphology of lipid droplets and mitochondria in granulosa cells, suggesting potential targets and mechanisms. Transcriptomic analysis and validation experiments collectively suggested that the beneficial effects of NMN on aging ovaries are mediated through enhanced mitochondrial function, improved energy metabolism, and reduced inflammation levels. Our results suggest that NMN supplementation could improve the health status of aging ovaries and enhance ovarian reserve, offering new insights into addressing fertility challenges in older women through assisted reproductive technology.

Keywords

infertility / nicotinamide adenine dinucleotide (NAD+) / nicotinamide mononucleotide / ovarian aging

References

[1] De Vos M, Smitz J, Woodruff TK. Fertility preservation in women with cancer. Lancet. 2014; 384(9950): 1302-1310.

[2] Sauer MV. Reproduction at an advanced maternal age and maternal health. Fertil Steril. 2015; 103(5): 1136-1143.

[3] Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev. 2009; 30(5): 465-493.

[4] Yao J, Li Z, Fu Y, et al. Involvement of obesity-associated upregulation of chemerin/chemokine-like receptor 1 in oxidative stress and apoptosis in ovaries and granulosa cells. Biochem Biophys Res Commun. 2019; 510(3): 449-455.

[5] Cuomo D, Ambrosino C. Non-coding RNAs as integrators of the effects of age, genes, and environment on ovarian aging. Cell Death Dis. 2019; 10(2): 88.

[6] te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update. 2002; 8(2): 141-154.

[7] May-Panloup P, Boucret L, Chao de la Barca JM, et al. Ovarian ageing: the role of mitochondria in oocytes and follicles. Hum Reprod Update. 2016; 22(6): 725-743.

[8] Nagaoka SI, Hassold TJ, Hunt PA. Human aneuploidy: mechanisms and new insights into an age-old problem. Nat Rev Genet. 2012; 13(7): 493-504.

[9] Franasiak JM, Forman EJ, Hong KH, et al. The nature of aneuploidy with increasing age of the female partner: a review of 15, 169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril. 2014; 101(3): 656-663. e651.

[10] Greaney J, Wei Z, Homer H. Regulation of chromosome segregation in oocytes and the cellular basis for female meiotic errors. Hum Reprod Update. 2018; 24(2): 135-161.

[11] Wei Y, Xu M, Liu X, et al. Single-cell transcriptome analysis of the mouse and primate ovaries reveals oocyte-specific expression patterns of risk genes in ovarian aging. MedComm. 2023; 4(2): e209.

[12] Huang F, Cao Y, Liang J, et al. The influence of the gut microbiome on ovarian aging. Gut Microbes. 2024; 16(1): 2295394.

[13] Liang J, Huang F, Song Z, Tang R, Zhang P, Chen R. Impact of NAD+ metabolism on ovarian aging. Immun Ageing. 2023; 20(1): 70.

[14] Kauppila TES, Kauppila JHK, Larsson NG. Mammalian mitochondria and aging: an update. Cell Metab. 2017; 25(1): 57-71.

[15] Sasaki H, Hamatani T, Kamijo S, et al. Impact of oxidative stress on age-associated decline in oocyte developmental competence. Front Endocrinol (Lausanne). 2019; 10: 811.

[16] McBride HM, Neuspiel M, Wasiak S. Mitochondria: more than just a powerhouse. Curr Biol. 2006; 16(14): R551-560.

[17] Wang T, Zhang M, Jiang Z, Seli E. Mitochondrial dysfunction and ovarian aging. Am J Reprod Immunol. 2017; 77(5).

[18] Seifer DB, DeJesus V, Hubbard K. Mitochondrial deletions in luteinized granulosa cells as a function of age in women undergoing in vitro fertilization. Fertil Steril. 2002; 78(5): 1046-1048.

[19] Prates EG, Nunes JT, Pereira RM. A role of lipid metabolism during cumulus-oocyte complex maturation: impact of lipid modulators to improve embryo production. Mediators Inflamm. 2014; 2014: 692067.

[20] Sturmey RG, O’Toole PJ, HJ Leese. Fluorescence resonance energy transfer analysis of mitochondrial:lipid association in the porcine oocyte. Reproduction. 2006; 132(6): 829-837.

[21] Dunning KR, Cashman K, Russell DL, Thompson JG, Norman RJ, Robker RL. Beta-oxidation is essential for mouse oocyte developmental competence and early embryo development. Biol Reprod. 2010; 83(6): 909-918.

[22] Allanson B, Jennings B, Jacques A, Charles AK, Keil AD, Dickinson JE. Infection and fetal loss in the mid-second trimester of pregnancy. Aust N Z J Obstet Gynaecol. 2010; 50(3): 221-225.

[23] Robker RL, Hennebold JD, Russell DL. Coordination of ovulation and oocyte maturation: a good egg at the right time. Endocrinology. 2018; 159(9): 3209-3218.

[24] Duffy DM, Ko C, Jo M, Brannstrom M, Curry TE. Ovulation: parallels with inflammatory processes. Endocr Rev. 2019; 40(2): 369-416.

[25] Prattichizzo F, Micolucci L, Cricca M, et al. Exosome-based immunomodulation during aging: a nano-perspective on inflamm-aging. Mech Ageing Dev. 2017; 168: 44-53.

[26] Navarro-Pando JM, Alcocer-Gomez E, Castejon-Vega B, et al. Inhibition of the NLRP3 inflammasome prevents ovarian aging. Sci Adv. 2021; 7(1).

[27] Cui LL, Yang G, Pan J, Zhang C. Tumor necrosis factor alpha knockout increases fertility of mice. Theriogenology. 2011; 75(5): 867-876.

[28] Uri-Belapolsky S, Shaish A, Eliyahu E, et al. Interleukin-1 deficiency prolongs ovarian lifespan in mice. Proc Natl Acad Sci USA. 2014; 111(34): 12492-12497.

[29] Bonkowski MS, Sinclair DA. Slowing ageing by design: the rise of NAD(+) and sirtuin-activating compounds. Nat Rev Mol Cell Biol. 2016; 17(11): 679-690.

[30] Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021; 372(6547): 1224-1229.

[31] Liao B, Zhao Y, Wang D, Zhang X, Hao X, Hu M. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. J Int Soc Sports Nutr. 2021; 18(1): 54.

[32] Miao Y, Cui Z, Gao Q, Rui R, Xiong B. Nicotinamide mononucleotide supplementation reverses the declining quality of maternally aged oocytes. Cell Rep. 2020; 32(5): 107987.

[33] Huang P, Zhou Y, Tang W, et al. Long-term treatment of nicotinamide mononucleotide improved age-related diminished ovary reserve through enhancing the mitophagy level of granulosa cells in mice. J Nutr Biochem. 2022; 101: 108911.

[34] Bertoldo MJ, Listijono DR, Ho WJ, et al. NAD(+) repletion rescues female fertility during reproductive aging. Cell Rep. 2020; 30(6): 1670-1681. e1677.

[35] Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde ER. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril. 2002; 77(2): 328-336.

[36] Yoshino J, Mills KF, Yoon MJ, Imai S. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet-and age-induced diabetes in mice. Cell Metab. 2011; 14(4): 528-536.

[37] Gomes AP, Price NL, Ling AJ, et al. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell. 2013; 155(7): 1624-1638.

[38] Mouchiroud L, Houtkooper RH, Moullan N, et al. The NAD(+)/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell. 2013; 154(2): 430-441.

[39] Mills KF, Yoshida S, Stein LR, et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab. 2016; 24(6): 795-806.

[40] Coccia ME, Rizzello F. Ovarian reserve. Ann N Y Acad Sci. 2008; 1127: 27-30.

[41] Erel CT, Ozcivit IB, Inan D, Mut A, Karakus Hatipoglu B, Konukoglu D. Serum kisspeptin levels along reproductive period in women: is it a marker for aging? Gynecol Endocrinol. 2022; 38(3): 267-272.

[42] Gurvich C, Le J, Thomas N, Thomas EHX, Kulkarni J. Sex hormones and cognition in aging. Vitam Horm. 2021; 115: 511-533.

[43] Bjorkgren I, Chung DH, Mendoza S, et al. Alpha/beta hydrolase domain-containing protein 2 regulates the rhythm of follicular maturation and estrous stages of the female reproductive cycle. Front Cell Dev Biol. 2021; 9: 710864.

[44] Yang Q, Cong L, Wang Y, et al. Increasing ovarian NAD(+) levels improve mitochondrial functions and reverse ovarian aging. Free Radic Biol Med. 2020; 156: 1-10.

[45] Wang L, Chen Y, Wei J, et al. Administration of nicotinamide mononucleotide improves oocyte quality of obese mice. Cell Prolif. 2022; 55(11): e13303.

[46] de Andrade Melo-Sterza F, Poehland R. Lipid metabolism in bovine oocytes and early embryos under in vivo, in vitro, and stress conditions. Int J Mol Sci. 2021; 22(7).

[47] Niu Y, Wang C, Xiong Q, et al. Distribution and content of lipid droplets and mitochondria in pig parthenogenetically activated embryos after delipation. Theriogenology. 2015; 83(1): 131-138.

[48] Niu YJ, Zhou W, Nie ZW, Shin KT, Cui XS. Melatonin enhances mitochondrial biogenesis and protects against rotenone-induced mitochondrial deficiency in early porcine embryos. J Pineal Res. 2020; 68(2): e12627.

[49] Choi J, Seo BJ, La H, et al. Comparative analysis of the mitochondrial morphology, energy metabolism, and gene expression signatures in three types of blastocyst-derived stem cells. Redox Biol. 2020; 30: 101437.

[50] Liang L, Chen Y, Yu Y, et al. SLC25A18 has prognostic value in colorectal cancer and represses Warburg effect and cell proliferation via Wnt signaling. Am J Cancer Res. 2020; 10(5): 1548-1567.

[51] Lunetti P, Cappello AR, Marsano RM, et al. Mitochondrial glutamate carriers from Drosophila melanogaster: biochemical, evolutionary and modeling studies. Biochim Biophys Acta. 2013; 1827(10): 1245-1255.

[52] Fakruzzaman M, Ghanem N, Bang JI, et al. Effect of peroxiredoxin II on the quality and mitochondrial activity of pre-implantation bovine embryos. Anim Reprod Sci. 2015; 159: 172-183.

[53] Paczkowski M, Schoolcraft WB, Krisher RL. Fatty acid metabolism during maturation affects glucose uptake and is essential to oocyte competence. Reproduction. 2014; 148(4): 429-439.

[54] Houten SM, Violante S, Ventura FV, Wanders RJ. The biochemistry and physiology of mitochondrial fatty acid beta-oxidation and its genetic disorders. Annu Rev Physiol. 2016; 78: 23-44.

[55] Rinaldo P, Matern D, Bennett MJ. Fatty acid oxidation disorders. Annu Rev Physiol. 2002; 64: 477-502.

[56] Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol. 2009; 9(8): 556-567.

[57] Blake SJ, Dougall WC, Miles JJ, Teng MW, Smyth MJ. Molecular pathways: targeting CD96 and TIGIT for cancer immunotherapy. Clin Cancer Res. 2016; 22(21): 5183-5188.

[58] Dougall WC, Kurtulus S, Smyth MJ, Anderson AC. TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy. Immunol Rev. 2017; 276(1): 112-120.

[59] Umehara T, Winstanley YE, Andreas E, et al. Female reproductive life span is extended by targeted removal of fibrotic collagen from the mouse ovary. Sci Adv. 2022; 8(24): eabn4564.

[60] Wu M, Huang Y, Zhu Q, et al. Adipose tissue and ovarian aging: potential mechanism and protective strategies. Ageing Res Rev. 2022; 80: 101683.

[61] Chiang JL, Shukla P, Pagidas K, et al. Mitochondria in ovarian aging and reproductive longevity. Ageing Res Rev. 2020; 63: 101168.

[62] Bailey-Downs LC, Tucsek Z, Toth P, et al. Aging exacerbates obesity-induced oxidative stress and inflammation in perivascular adipose tissue in mice: a paracrine mechanism contributing to vascular redox dysregulation and inflammation. J Gerontol A Biol Sci Med Sci. 2013; 68(7): 780-792.

[63] Smits MAJ, Schomakers BV, van Weeghel M, et al. Human ovarian aging is characterized by oxidative damage and mitochondrial dysfunction. Hum Reprod. 2023; 38(11): 2208-2220.

RIGHTS & PERMISSIONS

2024 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.